Lance's Corner

AHRQ Issues Regulatory Update

Jan 7, 2025

The Agency for Healthcare Research and Quality (AHRQ) has issued its weekly regulatory update, which can be read below.

January 7, 2025, Issue #943

 

AHRQ Stats: Trends in Prevalence of Common Healthcare-Associated Infections

Rates of several common healthcare-associated infections—including central line-associated bloodstream infections, catheter-associated urinary tract infections, methicillin-resistant Staphylococcus aureus infections and Clostridioides difficile infections—decreased by between 10.6 and 32.8 percent between 2016 and 2019. (Source: AHRQ Healthcare Cost and Utilization Project Statistical Brief #313, Prevalence and Burden of Healthcare-Associated Infections (HAIs), 2016-2021.)

Today's Headlines:

Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs

An AHRQ-supported article in Health Affairs discusses the potential of biosimilar drugs to unlock lower drug prices for patients. Biosimilars are much more affordable versions of comparable brand-name biologic drugs. Even after a disappointing economic performance in the decade following the Biologics Price Competition and Innovation Act of 2009, the biosimilar drug market has overcome patent hurdles and achieved remarkable progress, according to the authors. They examined adalimumab, the biosimilar alternative to Humira®, as a case study of the growing success of the biosimilar drug market in recent years. They suggested adjustments to the existing regulations to continue to boost production of biosimilar drugs and create cost savings across healthcare systems. Access the abstract.

 

Grantee Profile Highlights Work of Karen B. Lasater, Ph.D., R.N., To Study Nurse Staffing in a Public Health Emergency

LasaterAHRQ grantee Karen B. Lasater, Ph.D., R.N., associate professor of nursing at the University of Pennsylvania, is studying the impact that adequate nurse staffing in hospitals has on meeting the public’s healthcare needs both in ordinary times and during public health emergencies. Dr. Lasater, a senior fellow at Penn’s Leonard Davis Institute of Health Economics, received a three-year AHRQ grant in 2022 to assess the preparation, response and recovery of hospital nurses and patient outcomes during the COVID-19 pandemic. She and her colleagues are evaluating the extent to which hospital nursing resources (such as staffing) affected nurses’ performance and job satisfaction, and whether changes in patient outcomes paralleled changes in nurse outcomes and hospital nursing resources. Access more information about Dr. Lasater’s work as a first-time grantee, as well as profiles of other AHRQ grantees.

 

State Opioid Limits Have Minimal Impact on Postpartum Prescriptions

opioidsAn AHRQ-supported study published in JAMA Health Forum found that state-mandated restrictions on opioid prescriptions did little to reduce the prescribing of these medications to help women manage pain after birth. The authors examined postpartum claims data from 1,572,338 deliveries between 2014 and 2021. Cesarean deliveries, which are more likely than vaginal births to be associated with pain management medications, accounted for 32.3 percent of the deliveries studied. Researchers found that state limits were associated with only a statistically insignificant reduction in opioids prescribed, regardless of the type of delivery. These findings are consistent with those of other studies, demonstrating the ineffectiveness of state opioid limits for this vulnerable patient population. The authors suggested a need for more research and a more effective approach to protecting postpartum women from the risks associated with opioid use. Access the article.

 

AHRQ Signals Interest in Research on Menopause, Ageism and Emergency Department Boarding

Recently released notices from AHRQ highlight the agency’s interest in supporting research in key areas:

  • Special Emphasis Notice signals the agency’s interest in receiving grant applications for health services research on improving the diagnosis, treatment and management of perimenopause and menopausal symptoms. While safe and effective nonpharmacological and pharmacologic interventions are available to address menopausal symptoms, many are underutilized.
  • A Request for Information seeks information from the public to understand the effects of ageism on healthcare services and outcomes. AHRQ seeks evidence, insights or perspectives on the impact of ageism on care delivery and quality to identify barriers and explore opportunities to address age-related biases. Responses will inform future research priorities and studies, policies and initiatives.
  • A Special Emphasis Notice announces the agency’s interest in receiving grant applications to address emergency department boarding and hospital crowding so patients receive timely, condition-appropriate care. AHRQ’s interest includes research on care solutions that comply with the Emergency Medical Treatment and Labor Act, deliver effective systemwide emergency medical services, and reduce diagnostic error, staff burnout, and turnover.

 

Surveys Show Mixed Results on Patient and Workplace Safety Culture in Hospitals

surveysNew results from AHRQ’s Surveys on Patient Safety Culture® (SOPS®) program indicate patient safety culture within hospitals improved in several areas from 2022 to 2024, particularly related to staffing and work pace. Improvement was not seen in areas related to teamwork and among supervisors, managers or clinical leaders. Established in 2001, AHRQ’s Surveys on Patient Safety Culture® (SOPS®) Program conducts activities to understand, measure and improve patient safety culture in healthcare settings. Access more information about SOPS databases. Email questions to DatabasesOnSafetyCulture@westat.com or call (888) 324-9790.

 

Highlights From AHRQ’s Patient Safety Network

AHRQ’s Patient Safety Network (PSNet) highlights journal articles, books and tools related to patient safety. Articles featured this week include:

Review additional new publications in PSNet’s current issue, including recent cases and commentaries and AHRQ’s WebM&M (Morbidity and Mortality Rounds on the Web).

 

Register for Upcoming AHRQ Webinars

 

New Research and Evidence From AHRQ

AHRQ in the Professional Literature

Supplementing systematic review findings with healthcare system data: pilot projects from the Agency for Healthcare Research and Quality Evidence-based Practice Center program. Holmer HK, Iyer S, Fiordalisi CV, et al. J Clin Epidemiol. 2024 Oct;174:111484. Epub 2024 Aug 7. Access the abstract on PubMed®.

Evaluation of a primary care-integrated mobile health intervention to monitor between-visit asthma symptoms. Sulca Flores JA, Dalal AK, Sousa J, et al. Appl Clin Inform. 2024 Aug;15(4):785-97. Epub 2024 Oct 2. Access the abstract on PubMed®.

Testing and masking policies and hospital-onset respiratory viral infections. Pak TR, Chen T, Kanjilal S, et al. JAMA Netw Open. 2024 Nov 4;7(11):e2448063. Access the abstract on PubMed®.

A novel risk-adjusted metric to compare hospitals on their antibiotic prescribing at hospital discharge. Livorsi DJ, Merchant JA, Cho H, et al. Clin Infect Dis. 2024 Sep 26;79(3):588-95. Access the abstract on PubMed®.

Neighborhood-level social determinants of health and adolescent mental health. Oyegoke S, Hughes PM, Gigli KH. Acad Pediatr. 2024 Nov-Dec;24(8):1246-55. Epub 2024 Aug 17. Access the abstract on PubMed®.

Identifying factors influencing emerging innovations in hospital discharge decision making in response to system stress: a qualitative study. Gustavson AM, Miller MJ, Boening N, et al. BMC Health Serv Res. 2024 Oct 28;24(1):1293. Access the abstract on PubMed®.

Occurrence, predictors, and management of late vascular complications following extracorporeal membrane oxygenation. Banks CA, Blakeslee-Carter J, Nkie V, et al. J Vasc Surg. 2024 Sep;80(3):864-72.e1. Epub 2024 Apr 22. Access the abstract on PubMed®.

Outcomes by race and ethnicity following a Medicare bundled payment program for joint replacement. Kim N, Jacobson M. JAMA Netw Open. 2024 Sep 3;7(9):e2433962. Access the abstract on PubMed®.

Contact Information
For comments or questions about AHRQ News Now, contact Bruce Seeman, (301) 427-1998 or Bruce.Seeman@ahrq.hhs.gov.

 

USDOL Issues Comprehensive Employer Guidance on Long COVID

The United States Department of Labor (USDOL) has issued a comprehensive set of resources that can be accessed below for employers on dealing with Long COVID.

Supporting Employees with Long COVID: A Guide for Employers

The “Supporting Employees with Long COVID” guide from the USDOL-funded Employer Assistance and Resource Network on Disability Inclusion (EARN) and Job Accommodation Network (JAN) addresses the basics of Long COVID, including its intersection with mental health, and common workplace supports for different symptoms.  It also explores employers’ responsibilities to provide reasonable accommodations and answers frequently asked questions about Long COVID and employment, including inquiries related to telework and leave.

Download the guide

Accommodation and Compliance: Long COVID

The Long COVID Accommodation and Compliance webpage from the USDOL-funded Job Accommodation Network (JAN) helps employers and employees understand strategies for supporting workers with Long COVID.  Topics include Long COVID in the context of disability under the Americans with Disabilities Act (ADA), specific accommodation ideas based on limitations or work-related functions, common situations and solutions, and questions to consider when identifying effective accommodations for employees with Long COVID.  Find this and other Long COVID resources from JAN, below:

Long COVID, Disability and Underserved Communities: Recommendations for Employers

The research-to-practice brief “Long COVID, Disability and Underserved Communities” synthesizes an extensive review of documents, literature and data sources, conducted by the USDOL-funded Employer Assistance and Resource Network on Disability Inclusion (EARN) on the impact of Long COVID on employment, with a focus on demographic differences.  It also outlines recommended actions organizations can take to create a supportive and inclusive workplace culture for people with Long COVID, especially those with disabilities who belong to other historically underserved groups.

Read the brief

Long COVID and Disability Accommodations in the Workplace

The policy brief “Long COVID and Disability Accommodations in the Workplace” explores Long COVID’s impact on the workforce and provides examples of policy actions different states are taking to help affected people remain at work or return when ready.  It was developed by the National Conference of State Legislatures (NCSL) as part of its involvement in USDOL’s State Exchange on Employment and Disability (SEED) initiative.

Download the policy brief

Understanding and Addressing the Workplace Challenges Related to Long COVID

The report “Understanding and Addressing the Workplace Challenges Related to Long COVID” summarizes key themes and takeaways from an ePolicyWorks national online dialogue through which members of the public were invited to share their experiences and insights regarding workplace challenges posed by Long COVID.  The dialogue took place during summer 2022 and was hosted by USDOL and its agencies in collaboration with the Centers for Disease Control and Prevention and the U.S. Surgeon General.

Download the report

Working with Long COVID

The USDOL-published “Working with Long COVID” fact sheet shares strategies for supporting workers with Long COVID, including accommodations for common symptoms and resources for further guidance and assistance with specific situations.

Download the fact sheet

COVID-19: Long-Term Symptoms

This USDOL motion graphic informs workers with Long COVID that they may be entitled to temporary or long-term supports to help them stay on the job or return to work when ready, and shares where they can find related assistance.

Watch the motion graphic

A Personal Story of Long COVID and Disability Disclosure

In the podcast “A Personal Story of Long COVID and Disability Disclosure,” Pam Bingham, senior program manager for Intuit’s Diversity, Equity and Inclusion in Tech team, shares her personal experience of navigating Long COVID symptoms at work.  The segment was produced by the USDOL-funded Partnership on Employment and Accessible Technology (PEAT) as part of its ongoing “Future of Work” podcast series.

Listen to the podcast

HHS OIG Issues Annual Report on State MFCUs

Per the notice below, the Office of the Inspector General (OIG) of the United States Department of Health and Human Services (HHS) has issued its annual report on the performance of state Medicaid Fraud Control Units (MFCUs).

Medicaid Fraud Control Units Fiscal Year 2023 Annual Report (OEI-09-24-00200) 

Medicaid Fraud Control Units (MFCUs) investigate and prosecute Medicaid provider fraud and patient abuse or neglect. OIG is the Federal agency that oversees and annually approves federal funding for MFCUs through a recertification process. This new report analyzed the statistical data on annual case outcomes—such as convictions, civil settlements and judgments, and recoveries—that the 53 MFCUs submitted for Fiscal Year 2023.  New York data is as follows:

Outcomes

  • Investigations1 - 556
  • Indicted/Charged - 9
  • Convictions - 8
  • Civil Settlements/Judgments - 28
  • Recoveries2 - $73,204,518

Resources

  • MFCU Expenditures3 - $55,964,293
  • Staff on Board4 - 257

1Investigations are defined as the total number of open investigations at the end of the fiscal year.

2Recoveries are defined as the amount of money that defendants are required to pay as a result of a settlement, judgment, or prefiling settlement in criminal and civil cases and may not reflect actual collections.  Recoveries may involve cases that include participation by other Federal and State agencies.

3MFCU and Medicaid Expenditures include both State and Federal expenditures.

4Staff on Board is defined as the total number of staff employed by the Unit at the end of the fiscal year.

Read the Full Report

View the Statistical Chart

Engage with the Interactive Map

GAO Issues Report on Medicaid Managed Care Service Denials and Appeal Outcomes

The United States Government Accountability Office (GAO) has issued a report on federal use of state data on Medicaid managed care service denials and appeal outcomes.  GAO found that federal oversight is limited because it doesn't require states to report on Medicaid managed care service denials or appeal outcomes and there has not been much progress on plans to analyze and make the data publicly available.  To read the GAO report on federal use of state data on Medicaid managed care service denials and appeal outcomes, use the first link below.  To read GAO highlights of the report on federal use of state data on Medicaid managed care service denials and appeal outcomes, use the second link below.
https://www.gao.gov/assets/d24106627.pdf  (GAO report on federal use of state data on Medicaid managed care service denials and appeal outcomes)
https://www.gao.gov/assets/d24106627_high.pdf  (GAO highlights on federal use of state data on Medicaid managed care service denials and appeal outcomes)

CMS Issues Latest Medicare Regulatory Activities Update

The Centers for Medicare and Medicaid Services (CMS) has issued its latest update on its regulatory activities in the Medicare program.  While dentistry is only minimally connected to the Medicare program, Medicare drives the majority of health care policies and insurance reimbursement policies throughout the country.  Therefore, it always pays to keep a close eye on what CMS is doing in Medicare.  To read the latest CMS update on its regulatory activities in Medicare, use the link below.
https://www.cms.gov/training-education/medicare-learning-network/newsletter/2024-03-14-mlnc